Komatsu Y, Yoshii Y, Hyodo A, Nose T, Nagatomo Y, Kujiraoka Y, Ono Y
Department of Neurosurgery, University of Tsukuba.
No Shinkei Geka. 1992 Jun;20(6):663-8.
To assess the efficacy of surgical resection of brain metastases from patients with multiple brain metastases or/and with other systemic metastases, the authors analysed treatment results of 90 cases of metastatic brain tumors. The patients were divided into three groups. Group A (nine cases): Patients with single brain tumor and their primary cancers were well controlled. Their brain tumors were removed surgically and followed by radiation. Their mean survival time was 17.0 months, and 14.6 months were independent (Karnofsky score greater than or equal to 70) in cases of lung cancer. Five patients (55.6%) improved by treatment. Group B (21 cases): Patients with multiple brain metastases or/and with systemic metastases. Their brain tumor(s) which gave rise to neurological symptoms were surgically removed in order to improve their quality of life. In cases of lung cancer, mean survival time was 9.5 months and 7.1 months were independent. 11 patients (52.3%) improved by treatment. Group C (60 cases): Patients treated conservatively. Their mean survival time was 4.9 months and 2.7 months were independent in cases of lung cancer. Only 13 patients (21.7%) improved by treatment. However 23 (38.3%) deteriorated in their quality of life during treatment. Two patients of this group had single brain tumor and their primary cancers were controlled well. They refused surgery. Their mean survival time was 13.0 months, and 7.0 months were independent. These times were statistically shorter than group A. Seven patients had similar systemic and neurological states as those in group B. Their mean survival time was 5.0 months and 3.0 months were independent. These times were also statistically shorter than those in group B.(ABSTRACT TRUNCATED AT 250 WORDS)
为评估手术切除多发脑转移瘤患者或伴有其他全身转移瘤患者脑转移灶的疗效,作者分析了90例转移性脑肿瘤患者的治疗结果。患者被分为三组。A组(9例):单发脑肿瘤且原发癌得到良好控制的患者。他们的脑肿瘤通过手术切除,随后进行放疗。其平均生存时间为17.0个月,肺癌患者中独立生存时间(卡诺夫斯基评分大于或等于70)为14.6个月。5例患者(55.6%)治疗后病情改善。B组(21例):多发脑转移瘤或伴有全身转移瘤的患者。为改善生活质量,对引起神经症状的脑肿瘤进行手术切除。肺癌患者中,平均生存时间为9.5个月,独立生存时间为7.1个月。11例患者(52.3%)治疗后病情改善。C组(60例):保守治疗的患者。肺癌患者中,其平均生存时间为4.9个月,独立生存时间为2.7个月。只有13例患者(21.7%)治疗后病情改善。然而,该组有23例患者(38.3%)在治疗期间生活质量恶化。该组中有2例患者为单发脑肿瘤且原发癌控制良好。他们拒绝手术。其平均生存时间为13.0个月,独立生存时间为7.0个月。这些时间在统计学上短于A组。7例患者的全身和神经状态与B组相似。其平均生存时间为5.0个月,独立生存时间为3.0个月。这些时间在统计学上也短于B组。(摘要截选至250词)